Brent crude falls on renewed lockdowns, stronger dollar

Oil prices steadied on Monday after strong gains last week, as tough coronavirus lockdowns around the world renewed concerns about global fuel demand, while a stronger U.S. dollar also weighed on prices.

Stocks slip on virus fears, U.S. yields continue to climb

Stocks came off record highs on Monday partly on caution over rising coronavirus cases globally while elevated Treasury yields continued to support the dollar, which touched its highest since December against a basket of peers.

Ford to close Brazil manufacturing operations, take $4.1 billion in charges

Ford Motor Co said on Monday it will close its three plants in Brazil this year and take pretax charges of about $4.1 billion as the COVID-19 pandemic amplified the company's under use of its manufacturing capacity.

Twitter tumbles as Trump ban puts social media in spotlight

Twitter Inc's stock tumbled over 6% on Monday after its move to permanently suspend U.S. President Donald Trump's widely-followed account spurred concern among investors over the future regulation of social networks.

Analysis: U.S. IPO market faces first big test of 2021

At least eight businesses are set to price initial public offerings (IPOs) in New York in the next three days, seeking to raise a total of nearly $5 billion in what could be the biggest week for new listings in more than five years.

Wall Street retreats with earnings, Washington in view

Wall Street's main indexes slipped from record levels on Monday as investors took some profits as they waited for earnings season to begin and eyed events in Washington with caution.

U.S. bank quarterly profits expected to fall again from pre-COVID levels

When the biggest U.S. banks begin reporting fourth-quarter results on Friday some of the headlines could show profits plunged by as much as 40% from a year earlier, before the pandemic struck.

Novavax bosses cash out for $46 million with COVID-19 vaccine trials still under way

Top executives at U.S. pharmaceutical company Novavax Inc aren't waiting to see how well their COVID-19 vaccine works before they reap the financial rewards.

U.S. coffee shops will only return to pre-pandemic sales in 2023 - report

U.S. branded coffee shops will only return to pre-pandemic sales levels next year after the COVID-19 pandemic wiped out nearly a quarter of their turnover last year, according to Allegra World Coffee Portal, a research and consultancy firm.

Investors look to upcoming U.S. earnings for a view into 2021

Investors will be anxious to see whether upcoming quarterly reports and outlooks from U.S. companies validate expectations for a strong 2021 rebound in earnings and the economy, which were ravaged by the coronavirus pandemic last year.

Related Videos

BioNTech lifts vaccine target to 2 bln doses

Twitter shares drop after Trump account ban

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS